Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects.


Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
03 2020
Historique:
received: 26 08 2019
accepted: 19 11 2019
revised: 08 10 2019
pubmed: 4 12 2019
medline: 29 12 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

Much of the mechanistic research on anxiety focuses on subcortical structures such as the amygdala; however, less is known about the distributed cortical circuit that also contributes to anxiety expression. One way to learn about this circuit is to probe candidate regions using transcranial magnetic stimulation (TMS). In this study, we tested the involvement of the dorsolateral prefrontal cortex (dlPFC), in anxiety expression using 10 Hz repetitive TMS (rTMS). In a within-subject, crossover experiment, the study measured anxiety in healthy subjects before and after a session of 10 Hz rTMS to the right dorsolateral prefrontal cortex (dlPFC). It used threat of predictable and unpredictable shock to induce anxiety and anxiety potentiated startle to assess anxiety. Counter to our hypotheses, results showed an increase in anxiety-potentiated startle following active but not sham rTMS. These results suggest a mechanistic link between right dlPFC activity and physiological anxiety expression. This result supports current models of prefrontal asymmetry in affect, and lays the groundwork for further exploration into the cortical mechanisms mediating anxiety, which may lead to novel anxiety treatments.

Identifiants

pubmed: 31791039
doi: 10.1038/s41386-019-0583-5
pii: 10.1038/s41386-019-0583-5
pmc: PMC7021903
doi:

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

694-702

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
ID : ZIAMH002798
Pays : International

Références

Exp Brain Res. 2001 Oct;140(4):453-9
pubmed: 11685398
Science. 2004 Jan 9;303(5655):232-5
pubmed: 14716015
J Neurosci. 2017 Sep 20;37(38):9160-9171
pubmed: 28842415
Clin Neurophysiol. 2008 Jan;119(1):71-9
pubmed: 18039593
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):2871-8
pubmed: 24501122
Neuroimage. 2016 Feb 15;127:86-96
pubmed: 26608241
J Abnorm Psychol. 1995 May;104(2):327-33
pubmed: 7790634
Am J Psychiatry. 2017 Dec 1;174(12):1163-1174
pubmed: 28715908
Ann Phys Rehabil Med. 2015 Sep;58(4):208-213
pubmed: 26319963
Neuroimage. 2012 Apr 15;60(3):1759-70
pubmed: 22209809
J Neurophysiol. 2011 May;105(5):2150-6
pubmed: 21346213
Brain. 1994 Aug;117 ( Pt 4):847-58
pubmed: 7922470
Trends Neurosci. 2012 Sep;35(9):527-35
pubmed: 22658924
Biol Psychiatry. 2007 Dec 1;62(11):1208-16
pubmed: 17573044
Elife. 2017 May 30;6:
pubmed: 28555565
Cereb Cortex. 2008 Sep;18(9):2077-85
pubmed: 18203694
Clin Neurophysiol. 2007 Mar;118(3):709-16
pubmed: 17188568
Int J Psychophysiol. 2017 Apr;114:24-30
pubmed: 28163133
Biol Psychol. 2004 Oct;67(1-2):219-33
pubmed: 15130532
Psychol Sci. 2009 Dec;20(12):1500-6
pubmed: 19906125
Psychopharmacology (Berl). 2002 May;161(3):233-47
pubmed: 12021826
Behav Brain Res. 2010 Dec 25;214(2):450-5
pubmed: 20600336
Biol Psychiatry. 2006 Oct 1;60(7):760-6
pubmed: 16631127
Int J Biomed Imaging. 2010;2010:
pubmed: 20689717
Transl Psychiatry. 2017 Nov 30;7(12):1266
pubmed: 29213110
Transl Psychiatry. 2018 Jan 31;8(1):33
pubmed: 29382815
Int J Psychophysiol. 1998 May;28(3):223-31
pubmed: 9545658
Psychiatry Res. 2007 Feb 28;154(2):103-14
pubmed: 17292590
Psychophysiology. 2016 Nov;53(11):1660-1668
pubmed: 27434207
Clin Neurophysiol. 2001 Apr;112(4):720
pubmed: 11332408
Neuropsychopharmacology. 2010 Jan;35(1):105-35
pubmed: 19693004
J Affect Disord. 2013 Jan 10;144(1-2):153-9
pubmed: 22858212
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:347-360
pubmed: 30312634
Psychophysiology. 2005 Jan;42(1):1-15
pubmed: 15720576
Biol Psychol. 2010 Dec;85(3):487-95
pubmed: 20923694
Emotion. 2008 Jun;8(3):410-3
pubmed: 18540756
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Neuropsychopharmacology. 2009 Mar;34(4):964-71
pubmed: 18800069
Int Rev Psychiatry. 2017 Apr;29(2):115-145
pubmed: 28443696
Psychophysiology. 2010 May 1;47(3):442-54
pubmed: 20070577
Neuropsychopharmacology. 2019 Nov;44(12):1999-2010
pubmed: 31226707
Brain Res Rev. 2007 Jan;53(1):63-88
pubmed: 16887192
J Neural Transm (Vienna). 2016 Oct;123(10):1121-31
pubmed: 27177877
Sleep. 2013 Jun 01;36(6):857-71
pubmed: 23729929
Sci Rep. 2015 Mar 10;5:8954
pubmed: 25752944
Psychophysiology. 2016 Aug;53(8):1241-55
pubmed: 27167717
Cereb Cortex. 2013 Aug;23(8):1874-83
pubmed: 22763169
Neuroimage. 2012 Mar;60(1):523-9
pubmed: 22178453
Cogn Affect Behav Neurosci. 2012 Sep;12(3):571-88
pubmed: 22644759
Psychopharmacology (Berl). 2008 Aug;199(3):421-37
pubmed: 18058089
Neuroimage. 2017 Mar 1;148:1-7
pubmed: 28062252
J Neural Transm (Vienna). 2017 Feb;124(Suppl 1):139-152
pubmed: 26659730
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:222-5
pubmed: 26736240
J Neurophysiol. 2012 Mar;107(5):1257-9
pubmed: 22072509
Brain Res. 2007 Jan 12;1128(1):120-9
pubmed: 17113573
Nat Protoc. 2012 Feb 23;7(3):527-32
pubmed: 22362158

Auteurs

Nicholas L Balderston (NL)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. nicholas.balderston@pennmedicine.upenn.edu.
Center for Neuromodulation in Depression and Stress, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA. nicholas.balderston@pennmedicine.upenn.edu.

Emily M Beydler (EM)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Camille Roberts (C)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Zhi-De Deng (ZD)

Noninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Thomas Radman (T)

Noninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Tiffany Lago (T)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Bruce Luber (B)

Noninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Sarah H Lisanby (SH)

Noninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Monique Ernst (M)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Christian Grillon (C)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH